HIF-1alpha: a Valid Therapeutic Target for Tumor Therapy
HIF-1α: a Valid Therapeutic Target for Tumor Therapy
2
조회
0
다운로드
6
인용
0
참고문헌
키워드
초록
Hypoxia plays a major role in the induction of angiogenesis during tumor development. One mechanism by which tumor cells respond to a reduced oxygen level is via the activation of hypoxia-inducible factor-1 (HIF-1). HIF-1 is an oxygen-dependent transcriptional activator that plays crucial roles in the angiogenesis of tumors and mammalian development. HIF-1 consists of a constitutively expressed HIF-1β subunit and the highly regulated HIF-1α subunits. The stability and activity of HIF-1α are regulated by various post-translational modifications, hydroxylation, acetylation, phosphorylation and sumoyaltion. Therefore, HIF-1α interacts with several protein factors including PHD, pVHL, ARD-1, SUMO and p300/ CBP. Under normoxia, the HIF-1α subunit is rapidly degraded via the von Hippel-Lindau tumor suppressor gene product (pVHL)-mediated ubiquitin/proteasome pathway. The association of pVHL and HIF-1α under normoxic conditions is triggered by the hydroxylation of prolines and the acetylation of lysine within a polypeptide segment known as the oxygen-dependent degradation (ODD) domain. On the contrary, under the hypoxia condition, the HIF-1α subunit becomes stable and interacts with coactivators such as p300/CBP to modulate its transcriptional activity. Under hypoxic conditions, HIF-1 eventually acts as a master regulator of numerous hypoxia-inducible genes. The target genes of HIF-1 are especially related to angiogenesis, cell proliferation and survival, and to glucose and iron metabolism. Moreover, it was reported that the activation of HIF-1α is closely associated with a variety of tumors and oncogenic pathways. Hence, the blocking of HIF-1α itself or the blocking of HIF-1α interacting proteins inhibits tumor growth. Based on these findings, HIF-1 can be a prime target for anticancer therapies. Therefore, this review summarizes the molecular mechanism of HIF-1α stability, the biological functions of HIF-1 and its potential applications for cancer therapies.
Abstract
Hypoxia plays a major role in the induction of angiogenesis during tumor development. One mechanism by which tumor cells respond to a reduced oxygen level is via the activation of hypoxia-inducible factor-1 (HIF-1). HIF-1 is an oxygen-dependent transcriptional activator that plays crucial roles in the angiogenesis of tumors and mammalian development. HIF-1 consists of a constitutively expressed HIF-1β subunit and the highly regulated HIF-1α subunits. The stability and activity of HIF-1α are regulated by various post-translational modifications, hydroxylation, acetylation, phosphorylation and sumoyaltion. Therefore, HIF-1α interacts with several protein factors including PHD, pVHL, ARD-1, SUMO and p300/ CBP. Under normoxia, the HIF-1α subunit is rapidly degraded via the von Hippel-Lindau tumor suppressor gene product (pVHL)-mediated ubiquitin/proteasome pathway. The association of pVHL and HIF-1α under normoxic conditions is triggered by the hydroxylation of prolines and the acetylation of lysine within a polypeptide segment known as the oxygen-dependent degradation (ODD) domain. On the contrary, under the hypoxia condition, the HIF-1α subunit becomes stable and interacts with coactivators such as p300/CBP to modulate its transcriptional activity. Under hypoxic conditions, HIF-1 eventually acts as a master regulator of numerous hypoxia-inducible genes. The target genes of HIF-1 are especially related to angiogenesis, cell proliferation and survival, and to glucose and iron metabolism. Moreover, it was reported that the activation of HIF-1α is closely associated with a variety of tumors and oncogenic pathways. Hence, the blocking of HIF-1α itself or the blocking of HIF-1α interacting proteins inhibits tumor growth. Based on these findings, HIF-1 can be a prime target for anticancer therapies. Therefore, this review summarizes the molecular mechanism of HIF-1α stability, the biological functions of HIF-1 and its potential applications for cancer therapies.
참고문헌 (109)
- "Antitumor activity of the rapamycin analog CCI-779 in human primitive neuroectodermal tumor", medulloblastomamodels as single agent and in combination chemotherapy, 2001, pp.61, 1527~32
- "Angiogenesis in cancer and other disease", 407, pp.249~57 (2000)
- "Molecular pathology of cyclooxygenase-2 in neoplasia", 30, pp.3~21 (2000)
- "master and commander of thehypoxic world A pharmacological approach to its regulationby siRNAs", pp.971~1 80 (2004)
- "The effect of trastuzumab", docatexel combination on breast cancer angiogenesis dichotomus effect predictable by the HIFI alpha, pp.2003[DOI]
- "Targeting HIF-1 for cancer therapy", 3, pp.721~32 (2003)
- "Early stages of multistephepatocarcinogenesis", 22, pp.172~8 (1999)
- "Dramatic effect of ZD1839 ('Iressa') in a patientwith advanced non-small-cell lung cancer and poor performancestatus", 40, pp.73~6 (2003)
- "Prostaglandin E2 induces hypoxia-induciblefactor-1alpha stabilization and nuclear localization in a humanprostate cancer cell line", 277, pp.50081~6 (2002)
- "Effect of protein kinaseand phosphatase inhibitors on expression of HIF-1", 216, pp.669~75 (1995)
- "and transactivation properties of HIF-1α", pp.17771~8 (1996)
- "and enhance the transcriptionalactivity of HIF-1", pp.32631~7 (1999)
- "The thioredoxin redox inhibitors 1-methylpropyl2-imidazolyl disulfide and pleurotin inhibithypoxia- induced factor 1alpha and vascular endothelialgrowth factor formation", 2, pp.235~43 (2003)
- "Identification of amino acid residues critical for transcriptionalactivation and", or interaction with CREB-binding protein, 2002, 38723~30
- "Reduction of hypoxia-induced transcription through therepression of hypoxia-inducible factor-1alpha", aryl hydrocarbonreceptor nuclear translocator DNA binding by the 90-kDaheat-shock protein inhibitor radicicol, 2002, pp.62, 975~82
- "a transcription factor selectively expressed in endothelialcells", pp.72~82 (1997)
- "angiogenesis and growth of human breastcancer xenografts", so(o h), pp.1342~51 (2001), inhibits expressionof hypoxia-inducible factor-1alpha and vascular endothelialgrowth factor
- "Identificationof alternative spliced variants of human hypoxicinduciblefactor-1alpha", 275, pp.6922~7 (2000)
- "structural requirementof bisphenol A for degradation of HIF-1alpha", pp.1006~11 (2004)
- "Anew HIF-1 alpha variant induced by zinc ion suppresses HIF-1- mediated hypoxic responses", 114, pp.4051~61 (2001)
- "Berberineinhibits HIF-1alpha expression via enhanced proteolysis", 66, pp.612~9 (2004)
- "A dominantnegativeisoform lacking exon 11 and 12 of the humanhypoxic- inducible factor-1 α gene", 362, pp.71~9 (2002)
- "an inhibitor of hypoxia-inducible factor-1alpha", pp.233~478 44 (2004)
- "Phorbol ester stimulates the nonhypoxic induction of anovel hypoxia-inducible factor 1α isoform:implications fortumor promotion", 63, pp.8700~7 (2003)
- "GL331 inhibits HIF-1alpha expression in a lung cancermodel", 302, pp.95~100 (2003)
- "Non-hypoxic transcriptional activationof the aryl hydrocarbon receptor nuclear translocator inconcert with a novel hypoxia-inducible factor-1alpha isoform", 32, pp.5499~511 (2004)
- "HIFalpha targeted for VHL-mediated destruction by prolinehydroxylation:implications for O2 sensing", 292, pp.464~8 (2001)
- "Hepatitis B virus X protein induces angiogenesisby stabilizing hypoxia-inducible factor-1α", 18, pp.382~4 (2004)
- "Independent function of two destruction domains in hypoxiainduciblefactor-alpha chains activated by prolyl hydroxylation", 20, pp.5197~206 (2001)
- "Tid-1 interacts with pVHL and modulates angiogenesisby destabilization of HIF-1α"
- "The tumour suppressor protein VHL targets hypoxiainduciblefactors for oxygen-dependent proteolysis", 399, pp.271~5 (1999)
- "Mechanismof regulation of the hypoxia inducible factor-1 alpha by thevon Hipple-Lindau tumor suppressor protein", 19, pp.4298~309 (2000)
- "Multiple splice variants of the human HIF-3alpha locus aretargets of the VHL E3 ubiquitin ligase complex", 278, pp.11032~40 (2003)
- "is a hypoxia-induciblesplicing variant of the hypoxia-inducible factor-3α locus", pp.32405~8 (2002)
- "Hypoxia rapidly activates HIF-3α mRNAexpression", 17, pp.1541~3 (2003)
- "Expression of hypoxia-induciblefactor-1alpha and -2alpha in hypoxic and ischemic rat kidneys", 13, pp.1974~6 (2002)
- "The contribution of VHL substrate bindingand HIF-1alphaz to the phenotype of VHL loss in renal cellcarcinoma", 1, pp.247~55 (2002)
- "Inhibition of HIF is necessary for tumor suppression by thevon Hippel Lindau protein", 1, pp.237~46 (2002)
- "Relationship of hypoxia-inducible factor -1alpha andHIF-2alpha expression to vascular endothelial growth factorinduction and hypoxia survival in human breast cancer celllines", pp.7106~13 (2002)
- "Hypoxia-inducible factor-1a is modified by covalentattachment to SUMO Biology of Hypoxia The Role of Oxygen Sensing in Development", (rmal function and disease) (2004)
- "Expression of vascularendothelial growth factor in surgical specimens of hepatocellularcarcinoma", 126, pp.153~60 (2000)
- "MAP kinases and hypoxiain the control of VEGF expression", 19, pp.139~45 (2000)
- "Molecular mechanismsof blood vessel growth", 49, pp.507~21 (2001)
- "target for anti-vascularendothelial growth factor", pp.32~6 (2000)
- "A hypoxia-responsive element mediates a novel pathway ofactivation of the inducible nitric oxide synthase promoter", 182, pp.1683~93 (1995)
- "Hypoxiainduces type II NOS gene expression in pulmonary arteryendothelial cells via HIF-1", 274, pp.212~9 (1998)
- "Hypoxia-inducible factor-1 mediates transcriptional activationof the heme oxygenase-1 gene in response to hypoxia", 272, pp.5375~81 (1997)
- "Hypoxiaregulates expression of the endothelin-1 gene through aproximal hypoxia-inducible factor-1 binding site on theantisense strand", 245, pp.894~9 (1998)
- "Hypoxia regulates the expressionof the adrenomedullin and HIF-1 genes in cultured HL-1 cardiomyocytes", 265, pp.382~6 (1999)
- "Characterization ofthe alpha1B-adrenergic receptor gene promoter region andhypoxia regulatory elements in vascular smooth muscle", 94, pp.9487~92 (1997)
- "Cellular adaptation to hypoxia", pp.1151~62 (2002), and O2-regulated gene expression
- "Regulation of colon carcinoma cell invasionby hypoxia- inducible factor 1", 63, pp.1138~43 (2003)
- "Reciprocal positive regulation of hypoxia-inducible factor1alpha and insulin-like growth factor 2", 59, pp.3915~8 (1999)
- "Hypoxiaactivates a platelet-derived growth factor receptor", phosphatidylinositol3-kinase, pp.2001, 61[DOI]
- "Loss of PTEN facilitates HIF-1- mediated geneexpression", 14, pp.391~6 (2000)
- "Hypoxia--a key regulatory factor in tumour growth", 2, pp.38~47 (2002)
- "Oncogenic alterations of metabolism", 24, pp.68~72 (1999)
- "Transcription factor HIF-1 is a necessarymediator of the pasteur effect in mammalian cells", 21, pp.3436~44 (2001)
- "Regulationof glut1 mRNA by hypoxia-inducible factor-1", pp.9519~25 (2001)
- "Hypoxia-inducible expression of tumorassociatedcarbonic anhydrases", 60, pp.7075~83 (2000)
- "The role of phosphometabolitesin cell proliferation", pp.315~30 (1997)
- "Activation ofHIF depends primarily upon redox-sensitive stabilization of itsalpha subunit", pp.32253~9 (1996)
- "Activation of hypoxia-inducible factor 1alpha posttranscriptionalregulation and conformational change by recruitment ofthe Arnt transcription factor", pp.5667~72 (1997)
- "Structural basis for the recognition ofhydroxyproline in HIF-1α by pVHL", 417, pp.975~8 (2002)
- "Structure of an HIF-1α-pVHL complex:Hydroxyprolinerecognition in signalling", 296, pp.1886~9 (2002)
- "Sequence determinantsin hypoxia inducible factor-1α for hydroxylation by the prolylhydroxylases PHD1", pp.39792~800 (2002)
- "Intracellular localization of human HIF-1α hydroxylases Implications for oxygen sensing", pp.1319~26 (2003)
- "Induction of Hif-1alpha in response to hypoxiais instantaneous", 15, pp.1312~4 (2001)
- "Regulation and destabilization of HIF-1alpha byARD1-mediated acetylation", 111, pp.709~20 (2002)
- "Isolation of new genes in distal Xq28:transcriptionalmap and identification of a human holologue of the ARD1N-acetyl transferase of Saccharomyces cerevisiae", 3, pp.1061~7 (1994)
- "Genetic manipulation indicatesthat ARD1 is an essential N-acetyltransferase in Trypansomabrucei", 111, pp.309~17 (2000)
- "Mechanismof regulation of the hypoxia-inducible factor-1 alpha by thevon Hippel-Lindau tumor suppressor protein", 19, pp.4298~309 (2000)
- "Sumoylation increases HIF-1alpha stability and its transcriptionalactivity", 324, pp.394~400 (2004)
- "The expression and distribution of thehypoxia-inducible factors HIF-1alpha and HIF-2alpha innormal human tissues,cancers,and tumor-associated macrophages", 157, pp.411~21 (2000)
- "Overexpression of hypoxia-inducible factor1alpha in common human cancers and their metastases", 59, pp.5830~5 (1999)
- "Inductionof vascular endothelial growth factor by hypoxia is modulatedby a phosphatidylinositol 3-kinase", Akt signaling pathway inHa-ras-transformed cells through a hypoxia inducible factor-1transcriptional element, 1997, pp.90, 3322~31
- "Oxygen-dependentregulation of hypoxia-inducible factors by prolyl andasparaginyl hydroxylation", 270, pp.781~90 (2003)
- "The hypoxia- inducible factor-1 alpha isa negative factor for tumor therapy", 22, pp.3213~20 (2003)
- "Expression of hypoxia-inducible factor- 1alpha:a novel predictive and prognostic parameter in the radiotherapyof oropharyngeal cancer", 61, pp.2911~6 (2001)
- "Gene transfer of antisense hypoxia inducible factor-1alpha enhances the therapeutic efficacy of cancer immunotherapy", 8, pp.638~45 (2001)
- "Suppression of tumor growth through disruption of hypoxiainducibletranscription", 6, pp.1335~40 (2000)
- "Hsp90 regulates a von Hippel Lindau-independenthypoxia-inducible factor-1 alpha-degradative pathway", 277, pp.29936~44 (2002)
- "Geldanamycin induces degradation ofhypoxia- inducible factor 1alpha protein via the proteasomepathway in prostate cancer cells", 62, pp.2478~82 (2002)
- "Geldanamycin inhibits migration ofglioma cells in vitro a potential role for hypoxia-induciblefactor", pp.394~402 (2003)
- "YC-1:a potential anticancer drug targeting hypoxia-induciblefactor 1", 95, pp.516~25 (2003)
- "2ME2 inhibits tumor growth andangiogenesis by disrupting microtubules and dysregulatingHIF", 3, pp.363~75 (2003)
- "Targeting gene expression to hypoxictumor cells", 3, pp.515~20 (1997)
- "Anaerobic bacteria as a gene delivery systemthat is controlled by the tumor microenvironment", 4, pp.791~6 (1997)
- "Hypoxia-inducible factor1alpha protein expression is controlled by oxygen-regulatedubiquitination that is disrupted by deletions and missensemutations", 97, pp.4748~53 (2000)
- "Hypoxia inducible factor-alpha binding andubiquitylation by the von Hippel-Lindau tumor suppressorprotein", 275, pp.25733~41 (2000)
- "Activation of HIF1alpha ubiquitination by areconstituted von Hippel-Lindau", pp.10430~5 (2000), tumor suppressor complex
- "protein is rapidly degraded by the ubiquitin-proteasomesystem under normoxic conditions Its stabilization byhypoxia depends on redox-induced changes", pp.22642~7 (1997)
- "Regulation of tumor angiogenesis by p53-induceddegradation of hypoxia-inducible factor 1alpha", 14, pp.34~44 (2000)
- "Stabilization of wild-type p53 by hypoxiainduciblefactor 1alpha", 392, pp.405~8 (1998)
- "Molecular mechanisms of transcription activation by HLFand HIF1alpha in response to hypoxia:their stabilization andredox signal-induced interaction with CBP", p300, 1999, pp.18, 1905~14
- "An essential role for p300", CBP in the cellularresponse to hypoxia, 1996, pp.93, 12969~73
- "Redox-regulated recruitment of the transcriptionalcoactivators CREB-binding protein and SRC-1 tohypoxia- inducible factor 1alpha", 20, pp.402~15 (2000)
- "Hypoxia-induced activation of HIF-1:role of HIF-1alpha-Hsp90 interaction", 460, pp.251~6 (1999)
- "Jab1 interacts directly with HIF- 1alpha and regulatesits stability", 277, pp.9~12 (2002)
- "mediator of physiological and pathophysiologicalresponses to hypoxia", pp.1474~1 80 (2000)
- "Overexpression of hypoxiainduciblefactor 1alpha is associated with an unfavorableprognosis in lymph node-positive breast cancer", 8, pp.1831~7 (2002)
- "Significant correlation of hypoxia-induciblefactor-1alpha with treatment outcome in cervical cancer treatedwith radical radiotherapy", 56, pp.494~501 (2003)
- "Expression of hypoxia- inducible factor-1alpha in oligodendrogliomas:its impact on prognosis and onneoangiogenesis", 92, pp.165~71 (2001)
- "Relation of hypoxia inducible factor1 alpha and 2 alpha in operable non-small cell lung cancer toangiogenic", molecular profile of tumours and survival, 2001, pp.85, 881~90
- "Hypoxia-inducible factor-1alpha expression andangiogenesis in gastrointestinal stromal tumor of the stomach", 10, pp.797~802 (2003)
- "Hypoxia-inducible factors HIF- 1alpha and HIF-2alphain head and neck cancer:relationship to tumor biology andtreatment outcome in surgically resected patients", 62, pp.2493~7 (2002)
- "expression in early esophageal cancerand response to photodynamic therapy and radiotherapy"
- "Discovery of anovel Raf kinase inhibitor", 8, pp.219~25 (2001)
- "Identification of small moleculeinhibitors of hypoxia-inducible factor 1 transcriptionalactivation pathway", 62, pp.4316~24 (2002)
